Recruiting Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency NCT05879757 Conditions Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more Locations Instituto Privado de Investigaciones Clinicas de Cordoba — Córdoba, Argentina Fakultni nemocnice Plzen — Pilsen, Czechia Vseobecna fakultni Nemocnice — Prague, Czechia CHU Amiens - Hopital Sud — Salouël, Somme, France View all 27 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project NCT06821880 Conditions Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more Locations Medizinische Universität Innsbruck — Innsbruck, Tyrolia, Austria Medizinische Universität Graz — Graz, Austria BKH Kufstein — Kufstein, Austria Onkologischer Schwerpunkt am Oskar-Helene-Heim — Berlin, Germany View more locations Show fewer locations Loading locations... View Trial Details
Completed Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study NCT01287689 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +5 more Locations Klinik für Neurologie, St. Josefs-Hospital der Ruhr-Univ. — Bochum, Germany Praxis für Hämatologie und Internistische Onkologie — Cologne, Germany Institute for Clinical Pharmacology — Dresden, Germany Klinik für Neurologie, Medizinische Hochschule — Hanover, Germany View more locations Show fewer locations Loading locations... View Trial Details
